avelumab

Pfizer

Pharma

Move over, AZ. Pfizer, Merck KGaA win I-O bladder cancer nod

AstraZeneca’s Imfinzi won its bladder cancer approval just last week—but it’s no longer the newest immuno-oncology med for the condition.

Carly Helfand May 9, 2017 1:30pm

Pfizer HQ

Pfizer, Merck score FDA nod for cancer fighter avelumab

Mar 23, 2017 4:55pm